UZ Brussel (university hospital)/Laarbeeklaan 101/1090 Brussel/Belgium
|Originally developed by:||UZ Brussel (Unit of Clinical Pharmacology and Pharmacotherapy)|
|Country of origin:||Belgium|
|Year of development:||2007 (admission) and 2012 (discharge)|
|Last updated:||Discharge tool received a last update in December 2012|
|Next update:||Possibly, in function of user comments|
|Available in the following languages:||Dutch only for the moment|
|Reason for not fulfilling the requirements:||Not available in English|
Type of tool: tool for information of patients and relatives, tool to generate the best possible medication list
The aim of both data collection forms is to ensure adequate, correct and complete information about medications at transition moments (mainly on admission and at discharge from hospital).
The admission tool is to be used in the hospital (by trained personnel) as a checklist to collect information from patients, their carers or community pharmacists/physicians on medications used at home/nursing home.
The admission tool is to be used by hospital personnel (physician/pharmacist/nurse) to collect information on drugs used by the patient at home or in a nursing home.
The discharge tool is to be used by hospital personnel (physician/pharmacist/nurse) to summarize drug information for patients, community pharmacist and physicians at hospital discharge.
Applicability (setting e.g. inpatient care, outpatient care, long term care etc.)
Admission tool: inpatient care;
discharge tool: outpatient care
Information on how the tool has been applied/tested in practice
The admission tool was validated by pharmacists (Steurbaut et al., Ann Pharmacother. 2010 Oct;44(10):1596-603) and is routinely used with a high level of satisfaction.
The discharge tool is still in a test environment.
Needed time for implementation
Just some basic training is needed before being able to start working with both tools. However, some level of drug knowledge is necessary.
Strengths and limitations
Both tools were designed to minimize drug information gaps at transition moments (hospital admission and discharge) both for patients and healthcare workers.
Limitations are that they are not yet available in an electronic format (i.e. integrated in the patient’s electronic medical file) and at present only available in Dutch.
Cornu et al., Ann Pharmacother. 2012 Jul-Aug;46(7-8):983-90
Discrepancies in medication information for the primary care physician and the geriatric patient at discharge.